FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17452211000001107: Co-careldopa 50mg/200mg modified-release tablets 50 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60404101000001118 Co-careldopa 50mg/200mg modified-release tablets 50 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60404201000001113 Co-careldopa 50mg/200mg modified-release tablets 50 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has VMP Co-careldopa 50mg/200mg modified-release tablets true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has VMP Carbidopa + levodopa 50mg/200mg m/r tablet false Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has VMP Co-careldopa 50mg/200mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sinemet CR 50mg/200mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Is a True Co-careldopa 50mg/200mg modified-release tablets 50 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start